Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-04-28

FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA, Inc. under an ANDA, representing a supplemental approval for this generic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)